Monoclonal antibodies for human non-small cell lung carinomas
US4737579A · kind A · utility
25Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1986 |
| Grant date | Apr 12, 1988 |
| Priority date | — |
| Expiry date | Jul 23, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel monoclonal antibodies which define antigens associated with human non-small cell lung carcinomas ("NSCLC"). The antibodies bind to normal human cells to a lesser degree than to tumor cells. The antibodies find use in diagnostic methods such as the detection of malignant cells associated with NSCLC and in therapeutic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.